(Q41452301)

30 September 2017

1 reference

title

Therapy of mycobacterial infections (English)

1 reference

30 September 2017

S M Holland

1

1 reference

30 September 2017

publication date

1 October 1996

1 reference

30 September 2017

published in

Research in Immunology

1 reference

30 September 2017

volume

147

1 reference

30 September 2017

issue

8-9

1 reference

30 September 2017

page(s)

572-581

1 reference

Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Stimulation with cytokines enhances penetration of azithromycin into human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Interferon decreases the growth inhibition of Mycobacterium avium-intracellulare complex by fresh human monocytes but not by culture-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Aerosolized interferon gamma for Mycobacterium avium-complex lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Growth of Mycobacterium avium in human monocytes: identification of cytokines which reduce and enhance intracellular microbial growth

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

The immunogenicity of recombinant Mycobacterium smegmatis bearing BCG genes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Auxotrophic vaccines for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Leprosy and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Infection with Mycobacterium avium complex in patients without predisposing conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Intranasal infection of beige mice with Mycobacterium avium complex: role of neutrophils and natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Interferon-gamma and Mycobacterium avium-intracellulare infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Interferon-gamma treatment for Mycobacterium avium-intracellular complex bacillemia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Effect of Treatment with Interferon- Alone in Visceral Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Low-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

Addition of immunotherapy with Mycobacterium w vaccine to multi-drug therapy benefits multibacillary leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2985224-8

7 January 2021

10.1016/S0923-2494(97)85224-8

Identifiers

DOI

1 reference

30 September 2017

1 reference